CNR2 anticorps (AA 329-356)
Aperçu rapide pour CNR2 anticorps (AA 329-356) (ABIN3030275)
Antigène
Voir toutes CNR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 329-356
-
Fonction
- CB2 Antibody / Cannabinoid Receptor 2
-
Purification
- Antigen affinity
-
Immunogène
- A portion of amino acids 329-356 from the human protein was used as the immunogen for this CB2 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the CB2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the CB2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CNR2 (Cannabinoid Receptor 2 (CNR2))
-
Autre désignation
- CB2
-
Sujet
- The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. Cannabinoid receptor 2 and cannabinoid receptor 1 (brain) (CNR1) have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
-
UniProt
- P34972
Antigène
-